NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

There's a fresh push to edit the genes of human embryos to prevent diseases and enhance characteristics that parents value.

There could be new hope for people aiming to fight obesity following a research breakthrough identifying certain ...

The latest announcement is out from Bio-Gene Technology Ltd. ( ($AU:BGT) ). Bio-Gene Technology Limited released its 2025 Annual Report, ...

Bio-Gene Technology Ltd. ( ($AU:BGT) ) has issued an announcement. Bio-Gene Technology Ltd. has released its Corporate Governance Statement, ...

A gene called ASDL, which helps synthesize DNA, differs between modern humans and our extinct human relatives. The findings ...

A gene called SDR42E1 has been identified as a key player in how our bodies absorb and process vitamin D. Researchers found that disabling this gene in colorectal cancer cells not only crippled ...

Bio-Gene Technology Ltd. has announced its 2024 Annual General Meeting to be held on November 29 as a hybrid event, allowing shareholders to participate either in-person in Melbourne or online.

In Australia, gene technology, including genetically modified and gene-edited crops, is regulated by the Office of the Gene Technology Regulator (OGTR).

In recent years, scientists have recovered genetic blueprints from the remains of dodo birds, more than 10,000 prehistoric humans, and frozen mammoths, a species that went extinct around 2000 BCE.

Under the Gene Technology Act 2000 (Commonwealth), gene edited crops were originally treated the same as genetically modified organisms.